Niiza, Japan

Yoshinobu Nagano


Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 55(Granted Patents)


Location History:

  • Niiza, JA (1977 - 1978)
  • Niiza, JP (1979 - 1983)
  • Tokyo, JP (1986 - 1991)

Company Filing History:


Years Active: 1977-1991

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovations of Yoshinobu Nagano

Introduction

Yoshinobu Nagano is a prominent inventor based in Niiza, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing novel compounds for treating tumors. With a total of 11 patents to his name, Nagano's work has had a substantial impact on medical research and drug development.

Latest Patents

Among his latest patents is the invention of 6-[p-[5-(1-imidazolyl)pentyloxy]phenoxy]-2,2-dimethyl-hexanoic acid. This novel phenoxy derivative is designed for use in pharmaceutical compositions aimed at treating tumors. Another significant patent involves a phenoxy imidazole compound, which includes various derivatives represented by a specific general formula. These compounds also have applications in pharmaceutical compositions for tumor treatment.

Career Highlights

Yoshinobu Nagano has built a successful career at Yamanouchi Pharmaceutical Company Ltd., where he has been instrumental in advancing pharmaceutical innovations. His expertise in developing new chemical entities has positioned him as a key figure in the industry.

Collaborations

Throughout his career, Nagano has collaborated with notable colleagues, including Masaru Iwanami and Tetsuya Maeda. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical products.

Conclusion

Yoshinobu Nagano's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of treatments for critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…